Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance

Martina Radić(Ruđer Bošković Institute), Neda Slade(Ruđer Bošković Institute), Maja Herak Bosnar(Ruđer Bošković Institute), Maja Sabol(Rudjer Boskovic Institute), Marko Dužević(Ruđer Bošković Institute), Ana Tadijan(Ruđer Bošković Institute), Anđela Horvat(Ruđer Bošković Institute), Ignacija Vlašić(Ruđer Bošković Institute), Maja Jazvinšćak Jembrek(Catholic University of Croatia)
International Journal of Molecular Sciences
August 31, 2022
Cited by 21


Related Papers